Skip Navigation


ToxSci Advance Access originally published online on December 9, 2005
Toxicological Sciences 2006 90(1):87-95; doi:10.1093/toxsci/kfj069
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
90/1/87    most recent
kfj069v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fisher, J. W.
Right arrow Articles by Almekinder, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fisher, J. W.
Right arrow Articles by Almekinder, T. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Effect of PCB 126 on Hepatic Metabolism of Thyroxine and Perturbations in the Hypothalamic-Pituitary-Thyroid Axis in the Rat

Jeffrey W. Fisher*,1, Jerry Campbell*, Srinivasa Muralidhara*, James V. Bruckner*, Duncan Ferguson*, Moiz Mumtaz{dagger}, Barry Harmon{ddagger}, Joan M. Hedge§, Kevin M. Crofton, Hekap Kim|| and Tara L. Almekinder*

* University of Georgia, Interdisciplinary Toxicology Program, Athens, Georgia 30602; {dagger} Agency for Toxic Substances and Disease Registry (ATSDR), NCEH/ATSDR/DT, Chamblee, GA 30341; {ddagger} University of Georgia, College of Veterinary Medicine, Department of Pathology, Athens, GA 30602; § USEPA/ORD/NHEERL, Neurotoxicology Division, Research Triangle Park, NC 27711; U.S. Environmental Protection Agency (USEPA/ORD/NHEERL) Neurotoxicology Division; and || Visiting Scientist, Department of Environmental Science, College of Natural Sciences, Kangwon, National University, Churcheon, Gangwon Do 200-701 South Korea

Received August 27, 2005; accepted November 23, 2005

The objective of this research was to examine the time- and dose- dependent disturbances in the hypothalamic-pituitary-thyroid (HPT) axis of adult male rats administered a potent coplanar (non-ortho) PCB, 3,3',4,4',5-pentachlorobiphenyl (PCB 126). Adult male Sprague-Dawley rats were administered a single oral bolus dose of 0, 7.5, 75, or 275 µg PCB 126/kg bw dissolved in corn oil. The rats were sacrificed periodically over 22 days. The 7.5-µg/kg dose induced hepatic ethoxyresorufin-O-deethylation EROD activity, but no changes were observed in hepatic uridine diphosphate glucuronyl transferases (UDPGTs) activity or serum TSH, T4, or fT4 concentrations. The two highest doses caused a modest decline in weight gain, induced hepatic EROD and UDPGT activities, increased serum TSH concentrations, and decreased serum T4 and fT4 concentrations. The amount of thyroxine glucuronide formed daily (pM/mg protein) increased linearly with the area-under-the-concentration-curve (AUCC) for PCB 126 in liver (µg/kg/day) and then slowed at the 275-µg/kg PCB 126 dose. Perturbations in the HPT axis were nonlinear with respect to PCB 126 dosing. As expected, an inverse relationship between the AUCC for serum T4 (µg/dl/day) and the AUCC for serum TSH (ng/dl/day) was observed; however, the relationship was highly nonlinear. These data support a mode of action for PCB 126 involving induction of hepatic UDPGTs by the aryl hydrocarbon receptor AhR. However, the dose-response characteristics of the HPT axis are nonlinear and complex, requiring sophisticated tools, such as PBPK models, to characterize dose response.

Key Words: PCB 126; thyroid hormones; P450, EROD; rat; TSH; UDPGT.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
E. Diamanti-Kandarakis, J.-P. Bourguignon, L. C. Giudice, R. Hauser, G. S. Prins, A. M. Soto, R. T. Zoeller, and A. C. Gore
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Endocr. Rev., June 1, 2009; 30(4): 293 - 342.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. D. Lehman-McKeeman
Beam Me Up Scotty: Incorporating Transporters in Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling
Toxicol. Sci., July 1, 2008; 104(1): 1 - 3.
[Full Text] [PDF]


Home page
Toxicol SciHome page
M. Lohitnavy, Y. Lu, O. Lohitnavy, L. S. Chubb, S. Hirono, and R. S. H. Yang
A Possible Role of Multidrug Resistance-Associated Protein 2 (Mrp2) in Hepatic Excretion of PCB126, an Environmental Contaminant: PBPK/PD Modeling
Toxicol. Sci., July 1, 2008; 104(1): 27 - 39.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. K. Kopec, D. R. Boverhof, L. D. Burgoon, D. Ibrahim-Aibo, J. R. Harkema, C. Tashiro, B. Chittim, and T. R. Zacharewski
Comparative Toxicogenomic Examination of the Hepatic Effects of PCB126 and TCDD in Immature, Ovariectomized C57BL/6 Mice
Toxicol. Sci., March 1, 2008; 102(1): 61 - 75.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
E. D. McLanahan, J. L. Campbell Jr, D. C. Ferguson, B. Harmon, J. M. Hedge, K. M. Crofton, D. R. Mattie, L. Braverman, D. A. Keys, M. Mumtaz, et al.
Low-Dose Effects of Ammonium Perchlorate on the Hypothalamic-Pituitary-Thyroid Axis of Adult Male Rats Pretreated with PCB126
Toxicol. Sci., June 1, 2007; 97(2): 308 - 317.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.